The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
40,000 visitors and representatives of more than 80 countries set to visit the show
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Subscribe To Our Newsletter & Stay Updated
